CGRP in human models of primary headaches

Håkan Ashina; Henrik Winther Schytz; Messoud Ashina

doi:10.1177/0333102416684344

CGRP in human models of primary headaches

Håkan Ashina, Henrik Winther Schytz, Messoud Ashina

Institut for Klinisk Medicin

9 Citationer (Scopus)

Abstract

Objective To review the role of CGRP in human models of primary headaches and to discuss methodological aspects and future directions. Discussion Provocation experiments demonstrated a heterogeneous CGRP migraine response in migraine patients. Conflicting CGRP plasma results in the provocation experiments are likely due to assay variation; therefore, proper validation and standardization of an assay is needed. To what extent CGRP is involved in tension-type headache and cluster headache is unknown. Conclusion Human models of primary headaches have elucidated the role of CGRP in headache pathophysiology and sparked great interest in developing new treatment strategies using CGRP antagonists and antibodies. Future studies applying more refined human experimental models should identify biomarkers of CGRP-induced primary headache and reveal whether CGRP provocation experiments could be used to predict efficacy of CGRP antagonists in migraine patients.

Originalsprog	Engelsk
Tidsskrift	Cephalalgia : an international journal of headache
Vol/bind	38
Udgave nummer	2
Sider (fra-til)	353-360
Antal sider	8
ISSN	0333-1024
DOI	https://doi.org/10.1177/0333102416684344
Status	Udgivet - 1 feb. 2018

Adgang til dokumentet

10.1177/0333102416684344

Citationsformater

@article{ad270282a19e46bd8767dc10e5adf0d3,

title = "CGRP in human models of primary headaches",

abstract = "Objective To review the role of CGRP in human models of primary headaches and to discuss methodological aspects and future directions. Discussion Provocation experiments demonstrated a heterogeneous CGRP migraine response in migraine patients. Conflicting CGRP plasma results in the provocation experiments are likely due to assay variation; therefore, proper validation and standardization of an assay is needed. To what extent CGRP is involved in tension-type headache and cluster headache is unknown. Conclusion Human models of primary headaches have elucidated the role of CGRP in headache pathophysiology and sparked great interest in developing new treatment strategies using CGRP antagonists and antibodies. Future studies applying more refined human experimental models should identify biomarkers of CGRP-induced primary headache and reveal whether CGRP provocation experiments could be used to predict efficacy of CGRP antagonists in migraine patients.",

keywords = "Analgesics/pharmacology, Biomarkers/metabolism, Calcitonin Gene-Related Peptide/antagonists & inhibitors, Cluster Headache/diagnosis, Humans, Migraine Disorders/diagnosis, Tension-Type Headache/diagnosis",

author = "H{\aa}kan Ashina and Schytz, {Henrik Winther} and Messoud Ashina",

year = "2018",

month = feb,

day = "1",

doi = "10.1177/0333102416684344",

language = "English",

volume = "38",

pages = "353--360",

journal = "Cephalalgia : an international journal of headache",

issn = "0333-1024",

publisher = "SAGE Publications",

number = "2",

}

TY - JOUR

T1 - CGRP in human models of primary headaches

AU - Ashina, Håkan

AU - Schytz, Henrik Winther

AU - Ashina, Messoud

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Objective To review the role of CGRP in human models of primary headaches and to discuss methodological aspects and future directions. Discussion Provocation experiments demonstrated a heterogeneous CGRP migraine response in migraine patients. Conflicting CGRP plasma results in the provocation experiments are likely due to assay variation; therefore, proper validation and standardization of an assay is needed. To what extent CGRP is involved in tension-type headache and cluster headache is unknown. Conclusion Human models of primary headaches have elucidated the role of CGRP in headache pathophysiology and sparked great interest in developing new treatment strategies using CGRP antagonists and antibodies. Future studies applying more refined human experimental models should identify biomarkers of CGRP-induced primary headache and reveal whether CGRP provocation experiments could be used to predict efficacy of CGRP antagonists in migraine patients.

AB - Objective To review the role of CGRP in human models of primary headaches and to discuss methodological aspects and future directions. Discussion Provocation experiments demonstrated a heterogeneous CGRP migraine response in migraine patients. Conflicting CGRP plasma results in the provocation experiments are likely due to assay variation; therefore, proper validation and standardization of an assay is needed. To what extent CGRP is involved in tension-type headache and cluster headache is unknown. Conclusion Human models of primary headaches have elucidated the role of CGRP in headache pathophysiology and sparked great interest in developing new treatment strategies using CGRP antagonists and antibodies. Future studies applying more refined human experimental models should identify biomarkers of CGRP-induced primary headache and reveal whether CGRP provocation experiments could be used to predict efficacy of CGRP antagonists in migraine patients.

KW - Analgesics/pharmacology

KW - Biomarkers/metabolism

KW - Calcitonin Gene-Related Peptide/antagonists & inhibitors

KW - Cluster Headache/diagnosis

KW - Humans

KW - Migraine Disorders/diagnosis

KW - Tension-Type Headache/diagnosis

U2 - 10.1177/0333102416684344

DO - 10.1177/0333102416684344

M3 - Review

C2 - 27940880

SN - 0333-1024

VL - 38

SP - 353

EP - 360

JO - Cephalalgia : an international journal of headache

JF - Cephalalgia : an international journal of headache

IS - 2

ER -

CGRP in human models of primary headaches

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater